R&D is the living heart of our company. Our strategy is based on patient-centric approach to develop generic products that meet emerging strict international standards at reasonable affordable cost.
Pipeline products ensure the local and regional leadership in anti-infective and sterile therapeutics.
R&D follow integrated development approach that take in consideration different product dimensions; formulation, analytical, package development. Products are developed in eCTD format according to ICH guidelines that meet quality, safety and efficacy requirements.
R&D activities are managed by multi-disciplinary team composed of scientists and pharmacists that focus on company vision. R&D directorate has a state of art infrastructure to meet the objectives. The directorate has 3 functions;